The Ectodermal Dysplasia Receptor Activates the Nuclear Factor-κB, JNK, and Cell Death Pathways and Binds to Ectodysplasin A
Open Access
- 1 January 2001
- journal article
- Published by Elsevier BV
- Vol. 276 (4), 2668-2677
- https://doi.org/10.1074/jbc.m008356200
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- TROY, a Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily, Exhibits a Homology with Edar and Is Expressed in Embryonic Skin and Hair FolliclesPublished by Elsevier BV ,2000
- Bcl-2 Prevents Caspase-independent Cell DeathPublished by Elsevier BV ,1998
- Death Receptors: Signaling and ModulationScience, 1998
- Dominant Negative Mutants of TRAF3 Reveal an Important Role for the Coiled Coil Domains in Cell Death Signaling by the Lymphotoxin-β ReceptorPublished by Elsevier BV ,1997
- Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient MiceImmunity, 1997
- TRAF2 Is Essential for JNK but Not NF-κB Activation and Regulates Lymphocyte Proliferation and SurvivalImmunity, 1997
- X–linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane proteinNature Genetics, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.The Journal of Experimental Medicine, 1996
- Induction of Apoptosis by the Low-Affinity NGF ReceptorScience, 1993